Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis by C. Gräni et al.
Comparison of myocardial fibrosis quantification methods by
cardiovascular magnetic resonance imaging for risk
stratification of patients with suspected myocarditis
Submitted by Beatrice Guillaumat on Wed, 03/06/2019 - 12:48
Titre Comparison of myocardial fibrosis quantification methods by cardiovascular magneticresonance imaging for risk stratification of patients with suspected myocarditis
Type de
publication Article de revue
Auteur
Gräni, Christoph [1], Eichhorn, Christian [2], Bière, Loïc [3], Kaneko, Kyoichi [4],
Murthy, Venkatesh L [5], Agarwal, Vikram [6], Aghayev, Ayaz [7], Steigner, Michael
[8], Blankstein, Ron [9], Jerosch-Herold, Michael [10], Kwong, Raymond Y [11]
Editeur BMC
Type Article scientifique dans une revue à comité de lecture
Année 2019
Langue Anglais




revue Journal of Cardiovascular Magnetic Resonance
ISSN 1532-429X
Mots-clés
Cardiovascular magnetic resonance imaging [12], CMR [13], Full width half maximum
[14], FWHM [15], MACE [16], Myocarditis [17], outcome [18], Quantification method
[19], Standard deviation SD [20]
Résumé en
anglais
BACKGROUND: Although the presence of late gadolinium enhancement (LGE) using
cardiovascular magnetic resonance imaging (CMR) is a significant discriminator of
events in patients with suspected myocarditis, no data are available on the optimal
LGE quantification method.
METHODS: Six hundred seventy consecutive patients (48 ± 16 years, 59% male) with
suspected myocarditis were enrolled between 2002 and 2015. We performed LGE
quantitation using seven different signal intensity thresholding methods based either
on 2, 3, 4, 5, 6, 7 standard deviations (SD) above remote myocardium or full width at
half maximum (FWHM). In addition, a LGE visual presence score (LGE-VPS) (LGE
present/absent in each segment) was assessed. For each of these methods, the
strength of association of LGE results with major adverse cardiac events (MACE) was
determined. Inter-and intra-rater variability using intraclass-correlation coefficient
(ICC) was performed for all methods.
RESULTS: Ninety-eight (15%) patients experienced a MACE at a medium follow-up of
4.7 years. LGE quantification by FWHM, 2- and 3-SD demonstrated univariable
association with MACE (hazard ratio [HR] 1.05, 95% confidence interval
[CI]:1.02-1.08, p = 0.001; HR 1.02, 95%CI:1.00-1.04; p = 0.001; HR 1.02, 95%CI:
1.00-1.05, p = 0.035, respectively), whereas 4-SD through 7-SD methods did not reach
significant association. LGE-VPS also demonstrated association with MACE (HR 1.09,
95%CI: 1.04-1.15, p < 0.001). In the multivariable model, FWHM, 2-SD methods, and
LGE-VPS each demonstrated significant association with MACE adjusted to age, sex,
BMI and LVEF (adjusted HR of 1.04, 1.02, and 1.07; p = 0.009, p = 0.035; and
p = 0.005, respectively). In these, FWHM and LGE-VPS had the highest degrees of
inter and intra-rater reproducibility based on their high ICC values.
CONCLUSIONS: FWHM is the optimal semi-automated quantification method in risk-
stratifying patients with suspected myocarditis, demonstrating the strongest
association with MACE and the highest technical consistency. Visual LGE scoring is a
reliable alternative method and is associated with a comparable association with
MACE and reproducibility in these patients.
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